- Latisse should not be applied to the lower lid.
- Lashes on each eye lid may not grow in the exact same way.
- Continued use of the drug is necessary to maintain the effect. Lashes will gradually return to pretreatment state if the use of Latisse is discontinued.
Thursday, January 15, 2009
Have you ever wished you had longer, darker lashes? Well, now there is an FDA approved drug that can help you with your wish. Friday, December 26, 2008, Allergan Inc. made the announcement.
The drug, Latisse, can be obtained by prescription only, so will be available through a doctor’s office.
The primary ingredient in Latisse, bimatoprost, is a prostaglandin analog that is present in hair. It is thought to help in the development and regrowth of hair follicles.
Latisse is applied once-daily to the base of the upper eyelashes with a sterile, single-use-per-eye disposable applicator. Users may begin to see results as early as six to eight weeks. However, it takes 16 weeks to see the full results.
Contraindications and Side Effects
The only known contraindication for use of Latisse is hypersensitivity to the drug.
Approximately 4% of users of Latisse will have side effects such as an itching sensation in the eyes and/or eye redness.
Pigmentation of the eyelids and iris may occur.
Other less common side effects which typically occur on the skin close to where Latisse is applied, or in the eyes include skin darkening, eye irritation, dryness of the eyes, and redness of the eyelids.
If you develop a new eye condition (e.g., trauma or infection), change in vision, have eye surgery, or develop any eye reactions (e.g. conjunctivitis and eyelid reactions), you should immediately seek your doctor's advice and consider discontinuing use of Latisse.
Other posts you may find interesting: